KUROS BIOSCIENCES AG NAM.-AKTIEN
KUROS BIOSCIENCES AG NAM.-AKTIEN/ CH0325814116 /
A2ALS5
|
10/09/2024 22:58:12
|
Chg.
+0.220
|
Volume |
Bid22:58:12 |
Ask22:58:12 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
19.220EUR
|
+1.16%
|
-
Turnover: - |
19.220Bid Size: - |
19.540Ask Size: - |
705.9 mill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-0.38 CHF |
-11.63% |
| EPS Diluted: |
- CHF |
65.22% |
| Revenues per Share: |
0.92 CHF |
86.57% |
| Book Value per Share: |
1.55 CHF |
-17.64% |
| Cash Flow per Share: |
-0.24 CHF |
20.33% |
| Dividend per Share: |
- CHF |
- |
| Total |
in mill. |
|
| Revenues: |
33.56 CHF |
86.57% |
| Net Income: |
-13.73 CHF |
-5.98% |
| Operating Cash Flow: |
-8.84 CHF |
- |
| Cash and Cash Equivalents: |
14.21 CHF |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
19.63 |
3.80 |
| P/BV ratio: |
11.62 |
2.25 |
| P/CF Ratio: |
-74.50 |
-14.43 |
| PEG: |
4.08 |
- |
| Earnings Yield: |
-2.11% |
-10.89% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
705.9 mill. EUR |
137.39 mill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
8.82 mill. EUR |
1.72 mill. EUR |
| Shares Outstanding: |
36.56 mill. |
|
Profitability
| Gross Profit Margin: |
71.31% |
| EBIT Margin: |
-39.30% |
| Net Profit Margin: |
-40.90% |
| Return on Equity: |
-24.20% |
| Return on Assets: |
-19.21% |
Financial Strength
| Liquidity I / Cash Ratio: |
107.74% |
| Liquidity II / Quick Ratio: |
156.36% |
| Liquidity III / Current Ratio: |
206.22% |
| Debt / Equity Ratio: |
26.01% |
| Dynam. Debt / Equity Ratio: |
-166.80% |
Efficiency
| Employees: |
80 |
| Personal Expenses / Employee: |
- CHF |
| Revenues / Employee: |
419,550.00 CHF |
| Net Income / Employee: |
-171,587.50 CHF |
| Total Assets / Employee: |
893,300.00 CHF |
| * Fiscal Year End: |
31/12/2023 |
| Accounting Standard: |
IFRS |
